NCT02308189

Brief Summary

A pilot randomized control trial (RCT) to generate effect sizes on the effects of blood flow restricted exercise on trunk extensor cross-sectional area (primary outcome), strength and endurance, whole body and regional lean mass and bone density, as well as the rate of recurrence of LBP (secondary outcomes).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Dec 2014

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 2, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 4, 2014

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2017

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

June 19, 2018

Completed
Last Updated

June 19, 2018

Status Verified

May 1, 2018

Enrollment Period

2 years

First QC Date

December 2, 2014

Results QC Date

April 3, 2018

Last Update Submit

May 18, 2018

Conditions

Keywords

Exercise

Outcome Measures

Primary Outcomes (1)

  • Trunk Extensor Muscle Cross Sectional Area % of Change

    The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by The primary endpoint is percent change in trunk extensor muscle cross-sectional area measured by MRI at week 10 (study day 70) after start of exercise training.

    Baseline and following 10-weeks of exercise training. Values are calculated from % change.

Secondary Outcomes (2)

  • Muscle Strength % of Change

    Baseline and following 10-weeks of exercise training. Values calculated are % of change

  • Muscle Endurance (Time to Task Failure) % of Change

    Baseline and following 10-weeks of exercise training. Values are calculated on % of change.

Study Arms (2)

Exercise

ACTIVE COMPARATOR

Low load resistance exercise training

Behavioral: Exercise

Exercise with blood flow restriction

EXPERIMENTAL

Low load resistance exercise training with blood flow restriction

Behavioral: Exercise with blood flow restriction

Interventions

Low load resistance exercise performed with an external pressure cuff applied over both legs or both arms during respective leg and arm exercises.

Also known as: Kaatsu Training with Blood Flow Restricted Exercise
Exercise with blood flow restriction
ExerciseBEHAVIORAL

Low load resistance exercise performed with no external pressure cuff applied to the appendicular limbs.

Also known as: Resistance exercise
Exercise

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women aged 18 to 50 years, with no significant health issues or conditions that, in the investigator's opinion, would limit the subject's ability to complete the study per protocol or that would impact the capability to get an accurate measurement of study endpoints.
  • Answer yes to the following question: Have you had two or more episodes of low back pain in the past 12-months with at least one of the episodes causing a restriction of work or leisure time activity?
  • Exhibit low trunk extensor endurance defined as the time to task failure during the modified-Sorenson test of less than 176 seconds.
  • Body mass index (BMI) between 19 and 37 kg/m2 inclusive.
  • With no condition that could limit participation in supervised resistance training exercise based on the Physical Activity Readiness Questionnaire (PAR-Q) (i.e., if a study participant answers yes to questions 1-4 they will be excluded, if they answer yes to 5-7 they will require clearance for participation by the study physician).
  • Sedentary lifestyle defined by a classification of "low" or "moderate" levels of physical activity based on the scoring criteria for the International Physical Activity Questionnaire (IPAQ).
  • Willing to maintain current diet and adhere to exercise programs described for the study and to not start any new dieting/weight management programs.
  • Willing and able to return for all clinic visits and complete all study-related procedures.
  • Able to read, understand, and complete study-related questionnaires
  • Able to read and understand, and willing to sign the informed consent form (ICF).

You may not qualify if:

  • Participation in progressive resistance exercise within the previous 24 weeks prior to screening.
  • Participation in any clinical trial within 24 weeks prior to screening.
  • Hospitalization (medical confinement for ≥24 hours), or immobilization, or major surgical procedure requiring general anesthesia within 24 weeks prior to screening, or any planned surgical procedures during the study period.
  • Limb amputation (except for toes) and/or any fracture within 24 weeks.
  • Osteoarthritis, rheumatologic diseases or orthopedic disorders which will not allow completion of the motions required for the resistance exercise.
  • Conditions (such as myasthenia gravis, myositis, muscular dystrophy or myopathy, including drug-induced myopathy) leading to muscle loss, muscle weakness, muscle cramps or myalgia.
  • Chronic or relapsing/remitting gastrointestinal disorders such as inflammatory bowel diseases, irritable bowel syndrome or gastrointestinal infections within 28 days of screening.
  • Acute viral or bacterial upper or lower respiratory infection at screening
  • Moderate or severe chronic obstructive pulmonary disease.
  • Back pain greater than 4 (on a 10 point numeric pain rating scale) at screening
  • Leg length discrepancy \> 3 cm.
  • Current or recent (i.e., within 12 weeks) of narcotics or muscle relaxants.
  • Currently pregnant (confirmed via a urine test) or planning to become pregnant within the next year at screening.
  • Report unexplained weight loss over the past 30 days (\> 10 pounds).
  • Report having pending litigation related to low back pain or currently receiving disability for low back pain.
  • +19 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ohio Musculoskeletal and Neurological Institute (OMNI) at Ohio University

Athens, Ohio, 45701, United States

Location

Related Publications (1)

  • Amano S, Ludin AF, Clift R, Nakazawa M, Law TD, Rush LJ, Manini TM, Thomas JS, Russ DW, Clark BC. Effectiveness of blood flow restricted exercise compared with standard exercise in patients with recurrent low back pain: study protocol for a randomized controlled trial. Trials. 2016 Feb 12;17:81. doi: 10.1186/s13063-016-1214-7.

MeSH Terms

Conditions

Low Back PainMotor Activity

Interventions

ExerciseResistance Training

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, Human

Results Point of Contact

Title
Brian Clark, PhD
Organization
Ohio University

Study Officials

  • Brian C Clark, PhD

    Ohio Musculoskeletal and Neurological Institute (OMNI)

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 2, 2014

First Posted

December 4, 2014

Study Start

December 1, 2014

Primary Completion

November 24, 2016

Study Completion

May 24, 2017

Last Updated

June 19, 2018

Results First Posted

June 19, 2018

Record last verified: 2018-05

Data Sharing

IPD Sharing
Will not share

Locations